Staar Surgical Q1 2024 GAAP EPS $(0.07) Beats $(0.11) Estimate
Portfolio Pulse from Benzinga Newsdesk
Staar Surgical (NASDAQ:STAA) reported Q1 2024 GAAP EPS of $(0.07), surpassing the analyst consensus estimate of $(0.11) by 36.36 percent.
May 07, 2024 | 8:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Staar Surgical reported a smaller loss than expected in Q1 2024, with a GAAP EPS of $(0.07) versus the estimated $(0.11).
Beating earnings estimates typically has a positive impact on a company's stock price in the short term as it indicates better financial health and performance than expected by analysts. Staar Surgical's better-than-expected loss per share suggests operational efficiency or higher revenues, which could lead to increased investor confidence and a potential rise in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100